Company
RayzeBio, Inc.
RayzeBio, Inc. has 2 drugs tracked on RxWires: 2 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| RYZ711 | Phase 1/2 | Prostate Cancer (Adenocarcinoma) |
| RYZ101 | Phase 1/2 | Metastatic Breast Cancer |
Latest
No recent events.
Follow RayzeBio, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.